Hostname: page-component-586b7cd67f-tf8b9 Total loading time: 0 Render date: 2024-11-25T11:02:46.300Z Has data issue: false hasContentIssue false
  • English
  • Français

Serum Iron Abnormalities in Neuroleptic-Induced Akathisia in Schizophrenic Patients

Published online by Cambridge University Press:  02 January 2018

Som D. Soni ,
David Tench  and
R. C. Routledge
Som D. Soni*
Affiliation:
Department of Psychological Medicine, University of Manchester School of Medicine, Hope Hospital, Eccles Old Road, Salford M6 8HD
David Tench
Affiliation:
Department of Psychological Medicine, University of Manchester School of Medicine
R. C. Routledge
Affiliation:
University of Manchester School of Medicine
*
∗Correspondence
Get access Rights & Permissions [Opens in a new window]

Abstract

Twenty-two schizophrenic patients (DSM-III-R criteria) with clinically significant akathisia were matched with 22 schizophrenic patients without akathisia on the following variables: age, sex, diagnosis, duration of illness, and current treatment. Both groups were assessed using a variety of clinical rating scales and several parameters of serum iron status. The akathisic patients showed greater severity of clinical psychopathology, particularly positive symptoms, and an excess of extrapyramidal side-effects. We were unable to confirm any association between low serum iron and neuroleptic-induced akathisia in our sample of community-based patients.

Type
Brief Reports
Information
The British Journal of Psychiatry , Volume 163 , Issue 5 , November 1993 , pp. 669 - 672
Copyright
Copyright © Royal College of Psychiatrists, 1993 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

American Psychiatric Association (1987) Diagnostic and Statistical Manual of Mental Disorders (3rd edn, revised) (DSM-III-R). Washington, DC: APA.Google Scholar
Barton, A., Bowie, J. & Ebmeier, K. (1990) Low plasma iron status and akathisia. Journal of Neurology, Neurosurgery and Psychiatry, 53, 671–674.Google Scholar
Ben-Sachar, D., Finberg, J. P. M. & Youdim, M. B. H. (1985) Effect of iron chelators on dopamine D2 receptors. Journal of Neurochemistry, 45, 999–1005.CrossRefGoogle Scholar
Brown, K. W., Glen, S. E. & White, T. (1987) Low serum iron status and akathisia. Lancet, i, 1234–1236.Google Scholar
Krawiecka, M., Goldberg, D. P. & Vaughn, M. (1977) A standardised psychiatric assessment scale for rating chronic psychotic patients. Acta Psychiatrica Scandinavica, 35, 299–308.CrossRefGoogle Scholar
Machin, D. & Campbell, M. J. (1987) Statistical Tables for the Design of Clinical Trials. Oxford: Blackwell Scientific Publications.Google Scholar
National Institute of Mental Health (1975) Development of a dyskinetic movement scale. Early Clinical Drug Evaluation Unit Interco. Psychopharmacology Research, 4, 3–6.Google Scholar
Pasternak, G. W., Snowman, A. M. & Snyder, S. H. (1975) Selective enhancement of [3H] opiate agonist binding by divalent ions. Molecular Pharmacology, 11, 735–744.Google Scholar
Schooler, N. R. & Kane, J. M. (1982) Research diagnosis for tardive dyskinesia. Archives of General Psychiatry, 39, 486–487.Google Scholar
Simpson, G. M. & Angus, J. W. S. (1970) A rating scale for extrapyramidal side-effects. Acta Psychiatrica Scandinavica (suppl. 212), 11–19.Google Scholar
Soni, S. D., Mallik, A., Reed, P. F., et al (1992) Differences between chronic hospitalised schizophrenics and those living in the community: implications for clinical practice and research. Hospital and Community Psychiatry, 43, 1233–1238.Google Scholar
Submit a response

eLetters

No eLetters have been published for this article.